These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3361739)

  • 1. [In vitro and in vivo antimycobacterial activities of cefpimizole (AC-1370) and its effect on oxygen metabolism of host macrophages].
    Sato K; Saito H; Tomioka H
    Kekkaku; 1988 Jan; 63(1):19-25. PubMed ID: 3361739
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimycobacterial effect of cycloserine.
    Lucchesi M
    Scand J Respir Dis Suppl; 1970; 71():13-21. PubMed ID: 5317743
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action of antimycobacterial drugs.
    David HL; Laszlo A; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():189-94. PubMed ID: 2503988
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
    Dutta NK; Kumar KA; Mazumdar K; Dastidar SG
    Indian J Exp Biol; 2004 Sep; 42(9):922-7. PubMed ID: 15462188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of the mycobacterial cell wall.
    Nikaido H; Jarlier V
    Res Microbiol; 1991 May; 142(4):437-43. PubMed ID: 1871430
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory studies on the rimino-phenazines.
    Byrne J; Conalty ML; Jina A
    Tubercle; 1969 Mar; 50():Suppl:22-8. PubMed ID: 5407741
    [No Abstract]   [Full Text] [Related]  

  • 8. The mystery of the mycobacterial 'persistor'.
    Grange JM
    Tuber Lung Dis; 1992 Oct; 73(5):249-51. PubMed ID: 1493231
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).
    Moisan J; Wojciechowski W; Guilbault C; Lachance C; Di Marco S; Skamene E; Matlashewski G; Radzioch D
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3059-64. PubMed ID: 11600356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria.
    Burjanová B; Urbancik R
    Bibl Tuberc; 1970; 26():154-88. PubMed ID: 4983240
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal macrophage response in neonatal mice.
    Yang HY; Skinsnes OK
    J Reticuloendothel Soc; 1973 Aug; 14(2):181-91. PubMed ID: 4581956
    [No Abstract]   [Full Text] [Related]  

  • 12. [Editorial: Mycobacterial drug resistance in the German Democratic Republic].
    Steinbrück P
    Z Erkr Atmungsorgane; 1974; 140(3):264-5. PubMed ID: 4499424
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
    Tomioka H
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
    Janowiec M; Andrzejczyk Z; Szwedowicz I
    Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro and in vivo activities of chemically synthesized lipid A-subunit analogue, JTP3309, against mycobacterial infections in mice and in mouse peritoneal macrophages].
    Suzuki H; Saito H; Sato K; Tomioka H
    Kekkaku; 1995 Apr; 70(4):285-92. PubMed ID: 7760537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activity in Mycobacterium leprae infection.
    Sharp AK; Banerjee DK
    Acta Leprol; 1984; 2(2-4):259-66. PubMed ID: 6398585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytochemical and cytophysiological study of in vivo activated mouse peritoneal macrophages.
    Todoruţiu C; Mulea R; Daicoviciu D; Rişcă R
    Morphol Embryol (Bucur); 1981; 27(3):265-9. PubMed ID: 6460939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.